FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086977574> ?p ?o ?g. }

• W2086977574 endingPage "R51" @default.
• W2086977574 startingPage "R51" @default.
• W2086977574 abstract "Myocardial dysfunction necessitating inotropic support is a typical complication after on-pump cardiac surgery. This prospective, randomized pilot study analyzes the metabolic and renal effects of the inotropes adrenaline and milrinone in patients needing inotropic support after coronary artery bypass grafting (CABG).During an 18-month period, 251 patients were screened for low cardiac output upon intensive care unit (ICU) admission after elective, isolated CABG surgery. Patients presenting with a cardiac index (CI) of less than 2.2 liters/minute per square meter upon ICU admission - despite adequate mean arterial (titrated with noradrenaline or sodium nitroprusside) and filling pressures - were randomly assigned to 14-hour treatment with adrenaline (n = 7) or milrinone (n = 11) to achieve a CI of greater than 3.0 liters/minute per square meter. Twenty patients not needing inotropes served as controls. Hemodynamics, plasma lactate, pyruvate, glucose, acid-base status, insulin requirements, the urinary excretion of alpha-1-microglobuline, and creatinine clearance were determined during the treatment period, and cystatin-C levels were determined up to 48 hours after surgery (follow-up period).After two to four hours after ICU admission, the target CI was achieved in both intervention groups and maintained during the observation period. Plasma lactate, pyruvate, the lactate/pyruvate ratio, plasma glucose, and insulin doses were higher (p < 0.05) in the adrenaline-treated patients than during milrinone or control conditions. The urinary excretion of alpha-1-microglobuline was higher in the adrenaline than in the control group 6 to 14 hours after admission (p < 0.05). No between-group differences were observed in creatinine clearance, whereas plasma cystatin-C levels were significantly higher in the adrenaline than in the milrinone or the control group after 48 hours (p < 0.05).This suggests that the use of adrenaline for the treatment of postoperative myocardial dysfunction - in contrast to treatment with the PDE-III inhibitor milrinone - is associated with unwarranted metabolic and renal effects." @default.
• W2086977574 created "2016-06-24" @default.
• W2086977574 creator A5000536099 @default.
• W2086977574 creator A5006281970 @default.
• W2086977574 creator A5007287048 @default.
• W2086977574 creator A5012039437 @default.
• W2086977574 creator A5015846555 @default.
• W2086977574 creator A5021184112 @default.
• W2086977574 creator A5025559431 @default.
• W2086977574 creator A5026699589 @default.
• W2086977574 creator A5062691125 @default.
• W2086977574 date "2007-01-01" @default.
• W2086977574 modified "2023-09-30" @default.
• W2086977574 title "The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting" @default.
• W2086977574 cites W1600729955 @default.
• W2086977574 cites W1964348803 @default.
• W2086977574 cites W1967237457 @default.
• W2086977574 cites W1968695759 @default.
• W2086977574 cites W1978687198 @default.
• W2086977574 cites W1980717583 @default.
• W2086977574 cites W2002294971 @default.
• W2086977574 cites W2003372036 @default.
• W2086977574 cites W2004275522 @default.
• W2086977574 cites W2012158174 @default.
• W2086977574 cites W2012703052 @default.
• W2086977574 cites W2019639614 @default.
• W2086977574 cites W2023235203 @default.
• W2086977574 cites W2029883031 @default.
• W2086977574 cites W2029949452 @default.
• W2086977574 cites W2051543436 @default.
• W2086977574 cites W2052000998 @default.
• W2086977574 cites W2057350807 @default.
• W2086977574 cites W2068973347 @default.
• W2086977574 cites W2069431723 @default.
• W2086977574 cites W2075643834 @default.
• W2086977574 cites W2076780152 @default.
• W2086977574 cites W2114075528 @default.
• W2086977574 cites W2125568275 @default.
• W2086977574 cites W2133482423 @default.
• W2086977574 cites W2143737878 @default.
• W2086977574 cites W2149818341 @default.
• W2086977574 cites W2167200497 @default.
• W2086977574 cites W2171221927 @default.
• W2086977574 cites W2227698058 @default.
• W2086977574 cites W4242840156 @default.
• W2086977574 cites W67836030 @default.
• W2086977574 doi "https://doi.org/10.1186/cc5904" @default.
• W2086977574 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2206480" @default.
• W2086977574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17470271" @default.
• W2086977574 hasPublicationYear "2007" @default.
• W2086977574 type Work @default.
• W2086977574 sameAs 2086977574 @default.
• W2086977574 citedByCount "51" @default.
• W2086977574 countsByYear W20869775742012 @default.
• W2086977574 countsByYear W20869775742013 @default.
• W2086977574 countsByYear W20869775742014 @default.
• W2086977574 countsByYear W20869775742015 @default.
• W2086977574 countsByYear W20869775742016 @default.
• W2086977574 countsByYear W20869775742017 @default.
• W2086977574 countsByYear W20869775742018 @default.
• W2086977574 countsByYear W20869775742019 @default.
• W2086977574 countsByYear W20869775742020 @default.
• W2086977574 countsByYear W20869775742021 @default.
• W2086977574 countsByYear W20869775742022 @default.
• W2086977574 countsByYear W20869775742023 @default.
• W2086977574 crossrefType "journal-article" @default.
• W2086977574 hasAuthorship W2086977574A5000536099 @default.
• W2086977574 hasAuthorship W2086977574A5006281970 @default.
• W2086977574 hasAuthorship W2086977574A5007287048 @default.
• W2086977574 hasAuthorship W2086977574A5012039437 @default.
• W2086977574 hasAuthorship W2086977574A5015846555 @default.
• W2086977574 hasAuthorship W2086977574A5021184112 @default.
• W2086977574 hasAuthorship W2086977574A5025559431 @default.
• W2086977574 hasAuthorship W2086977574A5026699589 @default.
• W2086977574 hasAuthorship W2086977574A5062691125 @default.
• W2086977574 hasBestOaLocation W20869775741 @default.
• W2086977574 hasConcept C126322002 @default.
• W2086977574 hasConcept C139940330 @default.
• W2086977574 hasConcept C155710745 @default.
• W2086977574 hasConcept C164705383 @default.
• W2086977574 hasConcept C178853913 @default.
• W2086977574 hasConcept C2776645727 @default.
• W2086977574 hasConcept C2777260377 @default.
• W2086977574 hasConcept C2778789114 @default.
• W2086977574 hasConcept C31174226 @default.
• W2086977574 hasConcept C31861589 @default.
• W2086977574 hasConcept C42219234 @default.
• W2086977574 hasConcept C500558357 @default.
• W2086977574 hasConcept C71924100 @default.
• W2086977574 hasConceptScore W2086977574C126322002 @default.
• W2086977574 hasConceptScore W2086977574C139940330 @default.
• W2086977574 hasConceptScore W2086977574C155710745 @default.
• W2086977574 hasConceptScore W2086977574C164705383 @default.
• W2086977574 hasConceptScore W2086977574C178853913 @default.
• W2086977574 hasConceptScore W2086977574C2776645727 @default.
• W2086977574 hasConceptScore W2086977574C2777260377 @default.
• W2086977574 hasConceptScore W2086977574C2778789114 @default.
• W2086977574 hasConceptScore W2086977574C31174226 @default.

• next